所有图片(1)

主要文件

COO原产地证书/COA分析证书

查看所有文档

W261505

月桂醛

Name: 月桂醛
Brand: ALDRICH

≥95%, stabilized, FCC, FG

别名:

十二醛, 1-十二醛, 十二烷醛, 樟醛

登录查看公司和协议定价

所有图片(1)

About This Item

线性分子式:

CH₃(CH₂)₁₀CHO

CAS Number:

112-54-9

分子量:

184.32

FEMA编号:

2615

Beilstein:

1703917

EC 号:

203-983-6

欧洲委员会编号:

MDL编号:

MFCD00007017

UNSPSC代码:

12164502

PubChem化学物质编号:

24901206

Flavis编号:

5.011

NACRES:

NA.21

生物来源

synthetic

质量水平

300
400

等级

FG
Fragrance grade
Halal
Kosher

Agency

follows IFRA guidelines
meets purity specifications of JECFA

管理合规性

EU Regulation 1223/2009
EU Regulation 1334/2008 & 178/2002
FCC
FDA 21 CFR 117
FDA 21 CFR 172.515

方案

≥95%

包含

α-tocopherol as stabilizer

折射率

n20/D 1.435 (lit.)

沸点

185 °C/100 mmHg (lit.)

密度

0.831 g/mL at 25 °C (lit.)

应用

flavors and fragrances

文件

see Safety & Documentation for available documents

食品过敏原

no known allergens

致敏芳香化合物

no known allergens

性状检查

green; citrus; waxy; floral; soapy

SMILES字符串

CCCCCCCCCCCC=O

InChI

1S/C12H24O/c1-2-3-4-5-6-7-8-9-10-11-12-13/h12H,2-11H2,1H3

InChI key

HFJRKMMYBMWEAD-UHFFFAOYSA-N

一般描述

Lauric aldehyde is one of the main aliphatic green volatile compounds in macerated grape cluster stems. It is also one of the key flavor constituents of grapefruit oil.

应用

Utility of ToxTracker in animal alternative testing strategy for fragrance materials.: This study highlights the use of ToxTracker, a suite of reporter cell lines, to evaluate the genetic toxicity of fragrance materials, including lauric aldehyde, offering a potential alternative to animal testing and advancing the safety assessment of consumer products (Thakkar et al., 2023).

In vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin.: Research demonstrates the potential of hydrophobically-modified sulfated chitosan micelles, incorporating lauric aldehyde, for improving the delivery of chemotherapeutic agents, particularly doxorubicin, enhancing drug stability and reducing side effects (Wang et al., 2012).

Biocompatibility of injectable chitosan-phospholipid implant systems.: Investigates the biocompatibility of chitosan-phospholipid injectable implants, where lauric aldehyde could play a role in modifying polymer matrices to enhance biocompatibility and drug release profiles, critical for medical implant technologies (De Souza et al., 2009).